Nasopharyngeal mass were evaluated with WHO Response Evaluation criteria in Solid Tumors.
鼻咽病灶按WHO实体瘤疗效评价标准评价近期疗效。
参考来源 - 早期鼻咽癌后程三维适形放疗腮腺保护的临床研究·2,447,543篇论文数据，部分数据来源于NoteExpress
RECIST(Response Evaluation Criteria In Solid Tumors) was adopted as the new criteria recently.
RECIST已成为目前国际肿瘤界采用的新标准。
Objective: WHO criteria has been used to tumor response evaluation, however, the tumor cell log kill (LCK) and "curative" chemotherapy studies were not be reported in clinical research.
目的：临床以WHO标准评价疗效，尚无肿瘤细胞对数杀灭疗效评价及“治愈性”化疗研究报告。
In our third evaluation, we looked at the probe response time for each of the workloads.
在第三个评估场景中，我们将评估不同工作负载下的探针响应时间。
应用推荐